Carnitine metabolites and cognitive improvement in patients with schizophrenia treated with olanzapine: a prospective longitudinal study

Objective: Cognitive impairment is one of the core symptoms of schizophrenia, which is stable and lifelong. L-carnitine has been shown to improve cognitive function and decrease the rate of cognitive deterioration in patients with Alzheimer’s disease. However, it remains unclear regarding the role o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lei, Liu, Hua, Wang, Wenjuan, Wang, Youping, Xiu, Meihong, Li, Shuyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470116/
https://www.ncbi.nlm.nih.gov/pubmed/37663259
http://dx.doi.org/10.3389/fphar.2023.1255501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470116/
https://www.ncbi.nlm.nih.gov/pubmed/37663259
http://dx.doi.org/10.3389/fphar.2023.1255501

Ejemplares similares